Leerink Partnrs Increases Earnings Estimates for Amedisys

Amedisys, Inc. (NASDAQ:AMED) – Equities researchers at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for shares of Amedisys in a report issued on Wednesday, January 29th. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider will post earnings of $5.06 per share for the year, up from their previous forecast of $4.53. The consensus estimate for Amedisys’ current full-year earnings is $4.40 per share.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.98 earnings per share.

Amedisys Price Performance

Shares of AMED stock opened at $92.59 on Monday. The stock’s fifty day simple moving average is $89.47 and its 200 day simple moving average is $93.89. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market cap of $3.03 billion, a price-to-earnings ratio of 36.74, a P/E/G ratio of 1.82 and a beta of 0.73. Amedisys has a one year low of $82.15 and a one year high of $98.95.

Hedge Funds Weigh In On Amedisys

Large investors have recently made changes to their positions in the company. Blue Trust Inc. increased its holdings in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 124 shares during the last quarter. HBW Advisory Services LLC bought a new stake in Amedisys in the fourth quarter valued at about $38,000. Versant Capital Management Inc increased its holdings in Amedisys by 68.5% in the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 183 shares during the last quarter. KBC Group NV bought a new stake in Amedisys in the third quarter valued at about $63,000. Finally, Venturi Wealth Management LLC increased its holdings in Amedisys by 397.4% in the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider’s stock valued at $89,000 after purchasing an additional 779 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.